Ian Sabin
St Bartholomew's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ian Sabin.
European Journal of Endocrinology | 2011
Helen L. Storr; K I Alexandraki; L. Martin; Andrea M. Isidori; Gregory Kaltsas; John P. Monson; G. M. Besser; Matthew Matson; Jane Evanson; Fary Afshar; Ian Sabin; Martin O. Savage; Ashley B. Grossman
OBJECTIVE There are few published comparisons between paediatric and adult-onset Cushings disease (CD). We compare the epidemiology, diagnostic features and cure rate by transsphenoidal surgery (TSS) in these groups. DESIGN Retrospective review of patient databases in a single university hospital centre. PATIENTS Totally, 41 paediatric (mean age 12.3 ± 3.5 years; range 5.7-17.8) and 183 adult (mean age 40 ± 13 years; range 18.0-95.0) patients with CD were investigated. RESULTS Paediatric CD was characterised by male (63%) and adult CD by a female predominance (79%, P<0.0001). There were small but significant differences in clinical presentation. Biochemical features of CD were comparable except the serum cortisol increase during a CRH test: mean change (105%, n=39) in paediatric and (54%, n=123) in adult subjects (P<0.0001). Macroadenomas were more common in adult (15%, 28/183) than in paediatric (2%, 1/41, P=0.04) CD. Corticotroph microadenomas were more easily visualised by pituitary magnetic resonance imaging (MRI) in adult (76%, 50/66) compared with paediatric (55%, 21/38, P=0.045) CD with poorer concordance of imaging with surgical findings in children (P=0.058). The incidence of ACTH lateralisation by bilateral simultaneous inferior petrosal sinus sampling was comparable in paediatric (76%, 25/33) and adult (79%, 46/58; P=0.95) patients with good surgical concordance in both (82% paediatric and 79% adult). Cure rates by TSS were comparable, with a paediatric cure rate of 69%. CONCLUSION Several features of paediatric CD are distinct: increased frequency of prepubertal CD in males, the different clinical presentation, the decreased presence of macroadenomas and the frequent absence of radiological evidence of an adenoma on MRI.
Clinical Endocrinology | 2014
Helen L. Storr; William Drake; Jane Evanson; Matthew Matson; Daniel M. Berney; Ashley B. Grossman; John P. Monson; Ghassan Alusi; Martin O. Savage; Ian Sabin
Selective adenomectomy remains the first‐line treatment for Cushings disease (CD), until recently by microscopic transsphenoidal pituitary surgery. Endonasal transsphenoidal endoscopic surgery (ETES) is emerging as a novel, less invasive treatment for pituitary adenomas and has become the optimal surgical approach.
Case Reports | 2009
Mona Waterhouse; Ian Sabin; Nick Plowman; Tahseen A Chowdhury
The progress of a young woman presenting with diabetic ketoacidosis is described. She was managed as for a new presentation of type 1 diabetes, but was subsequently diagnosed with acromegaly due to a large pituitary tumour. Following treatment for this, and relative normalisation of growth hormone levels, she was able to stop insulin completely. Subsequently, an oral glucose tolerance test showed no evidence of abnormal glucose tolerance and she remains non-diabetic.
Hormone Research in Paediatrics | 2009
Philip A. Kelly; Karl Metcalfe; Jane Evanson; Ian Sabin; P. Nicholas Plowman; John P. Monson
Positron emission tomography (PET) with 18F-fluorodeoxy-glucose indicates metabolically active tissue. When investigating enhancing intracranial tumours, we have suggested that PET positivity might suggest an intracranial germ cell tumour (IGCT). Here, we present a case with dicentric IGCT where PET was initially discordant between the lesions and where PET then became negative despite clearly aggressive clinical behaviour. A cautionary note is introduced with respect to the interpretation of negative 18F-FDG PET when investigating enhancing intracranial lesions.
The Journal of Clinical Endocrinology and Metabolism | 2001
Gregory Kaltsas; Andrea M. Isidori; D. Florakis; Peter J Trainer; Cecilia Camacho-Hübner; F. Afshar; Ian Sabin; J. P. Jenkins; S. L. Chew; J. P. Monson; G. M. Besser; Ashley B. Grossman
The Journal of Clinical Endocrinology and Metabolism | 2005
Y. Sammy Woo; Andrea M. Isidori; Winnie Z. Wat; Gregory Kaltsas; F. Afshar; Ian Sabin; Paul J. Jenkins; John P. Monson; G. Michael Besser; Ashley B. Grossman
European Journal of Endocrinology | 2013
Krystallenia I Alexandraki; Gregory Kaltsas; Andrea M. Isidori; Helen L. Storr; Farhad Afshar; Ian Sabin; Shern L. Chew; William Drake; John P. Monson; G. Michael Besser; Ashley B. Grossman
European Journal of Endocrinology | 2005
Helen L. Storr; Farhad Afshar; Matthew Matson; Ian Sabin; Kate Davies; Jane Evanson; P. Nicholas Plowman; G. Michael Besser; John P. Monson; Ashley B. Grossman; Martin O. Savage
Pituitary | 2016
Galina Yordanova; Lee Martin; Farhad Afshar; Ian Sabin; Ghassan Alusi; Nicholas Plowman; Fiona Riddoch; Jane Evanson; Matthew Matson; Ashley B. Grossman; John P. Monson; William Drake; Martin O. Savage; Helen L. Storr
Endocrine Abstracts | 2017
Ingrid C.E. Wilkinson; Jane Evanson; Matthew Matson; Katherine Miszkiel; Joan Grieve; Ian Sabin; Farhad Afshar; Lee Martin; Ashley Grossman; Martin O Savage; William Drake; Helen L. Storr